In 2023, the mortality rate for trachea, bronchus, or lung malignant neoplasms in Germany stood at 53.8 deaths per hundred thousand persons. The forecasted data from 2024 to 2028 shows a slight decrease to 53.6, indicating stabilization. Year-on-year variations suggest a 0.2% annual decrease from 2023 to 2024, with maintenance at the same mortality rate through 2028. The five-year CAGR reflects negligible change, underscoring a plateau in mortality rates.
Future trends to monitor include advancements in medical treatments, early detection technologies, and public health initiatives targeting smoking cessation, which could further impact mortality rates positively. Changes in policy and healthcare access could also play a significant role in influencing these trends.
